PubMed:10352279
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-152 | Sentence | denotes | CD28 costimulation augments IL-2 secretion of activated lamina propria T cells by increasing mRNA stability without enhancing IL-2 gene transactivation. |
| T2 | 153-257 | Sentence | denotes | The pathways leading to activation in lamina propria (LP) T cells are different from peripheral T cells. |
| T3 | 258-340 | Sentence | denotes | LP T cells exhibit enhanced IL-2 secretion when activated through the CD2 pathway. |
| T4 | 341-411 | Sentence | denotes | Coligation of CD28 leads to synergistic enhancement of IL-2 secretion. |
| T5 | 412-646 | Sentence | denotes | Previous studies have characterized the CD28 augmentation of TCR-mediated signaling in peripheral blood T cells through transcriptional activation of an IL-2 promoter CD28 response element (CD28RE), along with enhanced mRNA stability. |
| T6 | 647-770 | Sentence | denotes | This study characterized molecular events involved in CD28 costimulation of IL-2 production in LP mononuclear cells (LPMC). |
| T7 | 771-895 | Sentence | denotes | LPMC exhibited increased IL-2 production in response to CD28 costimulation, compared with cells activated through CD2 alone. |
| T8 | 896-1008 | Sentence | denotes | IL-2 secretion was paralleled by increased expression of IL-2 mRNA, resulting from enhanced IL-2 mRNA stability. |
| T9 | 1009-1289 | Sentence | denotes | In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation. |
| T10 | 1290-1411 | Sentence | denotes | Furthermore, CD28 coligation fails to enhance IL-2 promoter-reporter or RE/AP construct expression in CD2-activated LPMC. |
| T11 | 1412-1641 | Sentence | denotes | The results reported herein indicate that the molecular mechanisms involved in CD28 cosignaling and regulation of IL-2 secretion in LP T cells are unique to that compartment and differ from those seen in peripheral blood T cells. |
| T12 | 1642-1816 | Sentence | denotes | These observations suggest a biological significance for different mechanisms of IL-2 activation in initiation and maintenance of the cytokine repertoire found in the mucosa. |
| T1 | 0-152 | Sentence | denotes | CD28 costimulation augments IL-2 secretion of activated lamina propria T cells by increasing mRNA stability without enhancing IL-2 gene transactivation. |
| T2 | 153-257 | Sentence | denotes | The pathways leading to activation in lamina propria (LP) T cells are different from peripheral T cells. |
| T3 | 258-340 | Sentence | denotes | LP T cells exhibit enhanced IL-2 secretion when activated through the CD2 pathway. |
| T4 | 341-411 | Sentence | denotes | Coligation of CD28 leads to synergistic enhancement of IL-2 secretion. |
| T5 | 412-646 | Sentence | denotes | Previous studies have characterized the CD28 augmentation of TCR-mediated signaling in peripheral blood T cells through transcriptional activation of an IL-2 promoter CD28 response element (CD28RE), along with enhanced mRNA stability. |
| T6 | 647-770 | Sentence | denotes | This study characterized molecular events involved in CD28 costimulation of IL-2 production in LP mononuclear cells (LPMC). |
| T7 | 771-895 | Sentence | denotes | LPMC exhibited increased IL-2 production in response to CD28 costimulation, compared with cells activated through CD2 alone. |
| T8 | 896-1008 | Sentence | denotes | IL-2 secretion was paralleled by increased expression of IL-2 mRNA, resulting from enhanced IL-2 mRNA stability. |
| T9 | 1009-1289 | Sentence | denotes | In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation. |
| T10 | 1290-1411 | Sentence | denotes | Furthermore, CD28 coligation fails to enhance IL-2 promoter-reporter or RE/AP construct expression in CD2-activated LPMC. |
| T11 | 1412-1641 | Sentence | denotes | The results reported herein indicate that the molecular mechanisms involved in CD28 cosignaling and regulation of IL-2 secretion in LP T cells are unique to that compartment and differ from those seen in peripheral blood T cells. |
| T12 | 1642-1816 | Sentence | denotes | These observations suggest a biological significance for different mechanisms of IL-2 activation in initiation and maintenance of the cytokine repertoire found in the mucosa. |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-4 | protein | denotes | CD28 |
| T2 | 28-32 | protein | denotes | IL-2 |
| T3 | 126-130 | protein | denotes | IL-2 |
| T4 | 191-218 | cell_type | denotes | lamina propria (LP) T cells |
| T5 | 238-256 | cell_type | denotes | peripheral T cells |
| T6 | 258-268 | cell_type | denotes | LP T cells |
| T7 | 286-290 | protein | denotes | IL-2 |
| T8 | 328-331 | protein | denotes | CD2 |
| T9 | 355-359 | protein | denotes | CD28 |
| T10 | 396-400 | protein | denotes | IL-2 |
| T11 | 452-456 | protein | denotes | CD28 |
| T12 | 473-476 | protein | denotes | TCR |
| T13 | 499-523 | cell_type | denotes | peripheral blood T cells |
| T14 | 565-569 | protein | denotes | IL-2 |
| T15 | 579-600 | DNA | denotes | CD28 response element |
| T16 | 602-608 | DNA | denotes | CD28RE |
| T17 | 701-705 | protein | denotes | CD28 |
| T18 | 723-727 | protein | denotes | IL-2 |
| T19 | 742-769 | cell_type | denotes | LP mononuclear cells (LPMC) |
| T20 | 771-775 | cell_type | denotes | LPMC |
| T21 | 796-800 | protein | denotes | IL-2 |
| T22 | 827-831 | protein | denotes | CD28 |
| T23 | 885-888 | protein | denotes | CD2 |
| T24 | 896-900 | protein | denotes | IL-2 |
| T25 | 953-962 | RNA | denotes | IL-2 mRNA |
| T26 | 988-997 | RNA | denotes | IL-2 mRNA |
| T27 | 1054-1058 | cell_type | denotes | PBMC |
| T28 | 1079-1083 | protein | denotes | CD28 |
| T29 | 1098-1116 | cell_type | denotes | CD2-activated LPMC |
| T30 | 1178-1184 | DNA | denotes | CD28RE |
| T31 | 1226-1239 | protein | denotes | I-kappaBalpha |
| T32 | 1243-1255 | protein | denotes | I-kappaBbeta |
| T33 | 1273-1277 | protein | denotes | CD28 |
| T34 | 1303-1307 | protein | denotes | CD28 |
| T35 | 1336-1358 | DNA | denotes | IL-2 promoter-reporter |
| T36 | 1362-1367 | protein | denotes | RE/AP |
| T37 | 1392-1410 | cell_type | denotes | CD2-activated LPMC |
| T38 | 1491-1495 | protein | denotes | CD28 |
| T39 | 1526-1530 | protein | denotes | IL-2 |
| T40 | 1544-1554 | cell_type | denotes | LP T cells |
| T41 | 1616-1640 | cell_type | denotes | peripheral blood T cells |
| T42 | 1723-1727 | protein | denotes | IL-2 |
| T43 | 1776-1795 | protein | denotes | cytokine repertoire |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-4 | protein_molecule | denotes | CD28 |
| T2 | 28-32 | protein_molecule | denotes | IL-2 |
| T3 | 126-130 | protein_molecule | denotes | IL-2 |
| T4 | 191-218 | cell_type | denotes | lamina propria (LP) T cells |
| T5 | 238-256 | cell_type | denotes | peripheral T cells |
| T6 | 258-268 | cell_type | denotes | LP T cells |
| T7 | 286-290 | protein_molecule | denotes | IL-2 |
| T8 | 328-331 | protein_molecule | denotes | CD2 |
| T9 | 355-359 | protein_molecule | denotes | CD28 |
| T10 | 396-400 | protein_molecule | denotes | IL-2 |
| T11 | 452-456 | protein_molecule | denotes | CD28 |
| T12 | 473-476 | protein_family_or_group | denotes | TCR |
| T13 | 499-523 | cell_type | denotes | peripheral blood T cells |
| T14 | 532-558 | other_name | denotes | transcriptional activation |
| T15 | 565-569 | protein_molecule | denotes | IL-2 |
| T16 | 579-583 | protein_molecule | denotes | CD28 |
| T17 | 602-608 | DNA_domain_or_region | denotes | CD28RE |
| T18 | 701-705 | protein_molecule | denotes | CD28 |
| T19 | 723-727 | protein_molecule | denotes | IL-2 |
| T20 | 742-764 | cell_type | denotes | LP mononuclear cells ( |
| T21 | 764-768 | cell_type | denotes | LPMC |
| T22 | 771-775 | cell_type | denotes | LPMC |
| T23 | 796-800 | protein_molecule | denotes | IL-2 |
| T24 | 827-831 | protein_molecule | denotes | CD28 |
| T25 | 885-888 | protein_molecule | denotes | CD2 |
| T26 | 896-900 | protein_molecule | denotes | IL-2 |
| T27 | 953-957 | protein_molecule | denotes | IL-2 |
| T28 | 988-992 | protein_molecule | denotes | IL-2 |
| T29 | 1054-1058 | cell_type | denotes | PBMC |
| T30 | 1060-1064 | other_name | denotes | EMSA |
| T31 | 1079-1083 | protein_molecule | denotes | CD28 |
| T32 | 1098-1101 | protein_molecule | denotes | CD2 |
| T33 | 1112-1116 | cell_type | denotes | LPMC |
| T34 | 1178-1184 | DNA_domain_or_region | denotes | CD28RE |
| T35 | 1194-1207 | other_name | denotes | Western blots |
| T36 | 1226-1239 | protein_molecule | denotes | I-kappaBalpha |
| T37 | 1243-1255 | protein_molecule | denotes | I-kappaBbeta |
| T38 | 1273-1277 | protein_molecule | denotes | CD28 |
| T39 | 1303-1307 | protein_molecule | denotes | CD28 |
| T40 | 1336-1340 | protein_molecule | denotes | IL-2 |
| T41 | 1362-1367 | protein_molecule | denotes | RE/AP |
| T42 | 1392-1395 | protein_molecule | denotes | CD2 |
| T43 | 1406-1410 | cell_type | denotes | LPMC |
| T44 | 1458-1478 | other_name | denotes | molecular mechanisms |
| T45 | 1491-1495 | protein_molecule | denotes | CD28 |
| T46 | 1526-1530 | protein_molecule | denotes | IL-2 |
| T47 | 1544-1554 | cell_type | denotes | LP T cells |
| T48 | 1616-1640 | cell_type | denotes | peripheral blood T cells |
| T49 | 1723-1727 | protein_molecule | denotes | IL-2 |
| T50 | 1776-1795 | protein_family_or_group | denotes | cytokine repertoire |
| T51 | 1809-1815 | tissue | denotes | mucosa |
semrep-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| E1-ti-1 | 0-4 | cui:C1332709 | denotes | CD28 |
| E2-ti-1 | 28-32 | cui:C0879590 | denotes | IL-2 |
| E3-ti-1 | 33-42 | cui:C0015283 | denotes | secretion |
| E4-ti-1 | 46-55 | cui:C1515877 | denotes | activated |
| E5-ti-1 | 56-70 | cui:C1179187 | denotes | lamina propria |
| E6-ti-1 | 71-78 | cui:C0039194 | denotes | T cells |
| E7-ti-1 | 82-92 | cui:C0442808 | denotes | increasing |
| E8-ti-1 | 93-107 | cui:C1257757 | denotes | mRNA stability |
| E9-ti-1 | 126-135 | cui:C0879590 | denotes | IL-2 gene |
| E10-ti-1 | 136-151 | cui:C0040624 | denotes | transactivation |
| T1 | 56-78 | PART_OF | denotes | lamina propria T cells |
| T2 | 43-45 | PART_OF | denotes | of |
| E1-ab-1 | 191-205 | cui:C1179187 | denotes | lamina propria |
| E2-ab-1 | 211-218 | cui:C0039194 | denotes | T cells |
| E3-ab-1 | 223-232 | cui:C1547020 | denotes | different |
| E4-ab-1 | 238-248 | cui:C0205100 | denotes | peripheral |
| E5-ab-1 | 249-256 | cui:C0039194 | denotes | T cells |
| T3 | 191-218 | PART_OF | denotes | lamina propria (LP) T cells |
| E1-ab-2 | 258-260 | cui:C1179187 | denotes | LP |
| E2-ab-2 | 261-268 | cui:C0039194 | denotes | T cells |
| E3-ab-2 | 286-290 | cui:C0879590 | denotes | IL-2 |
| E4-ab-2 | 291-300 | cui:C0015283 | denotes | secretion |
| E5-ab-2 | 328-331 | cui:C1367475 | denotes | CD2 |
| E6-ab-2 | 332-339 | cui:C0243123 | denotes | pathway |
| T4 | 258-268 | PART_OF | denotes | LP T cells |
| T5 | 306-315 | STIMULATES | denotes | activated |
| E1-ab-3 | 355-359 | cui:C1332709 | denotes | CD28 |
| E2-ab-3 | 396-400 | cui:C0879590 | denotes | IL-2 |
| E3-ab-3 | 401-410 | cui:C0015283 | denotes | secretion |
| T6 | 381-392 | STIMULATES | denotes | enhancement |
| E1-ab-4 | 412-420 | cui:C0205156 | denotes | Previous |
| E2-ab-4 | 421-428 | cui:C0008972 | denotes | studies |
| E3-ab-4 | 452-456 | cui:C1332709 | denotes | CD28 |
| E4-ab-4 | 457-469 | cui:C1293122 | denotes | augmentation |
| E5-ab-4 | 473-476 | cui:C0034790 | denotes | TCR |
| E6-ab-4 | 477-485 | cui:C0086597 | denotes | mediated |
| E7-ab-4 | 486-495 | cui:C0037083 | denotes | signaling |
| E8-ab-4 | 499-523 | cui:C0005773 | denotes | peripheral blood T cells |
| E9-ab-4 | 532-558 | cui:C0162493 | denotes | transcriptional activation |
| E10-ab-4 | 565-569 | cui:C0879590 | denotes | IL-2 |
| E11-ab-4 | 579-583 | cui:C1332709 | denotes | CD28 |
| E12-ab-4 | 584-600 | cui:C0600508 | denotes | response element |
| E13-ab-4 | 631-645 | cui:C1257757 | denotes | mRNA stability |
| T7 | 477-485 | AFFECTS | denotes | mediated |
| E1-ab-5 | 652-657 | cui:C0008972 | denotes | study |
| E2-ab-5 | 672-681 | cui:C1521991 | denotes | molecular |
| E3-ab-5 | 682-688 | cui:C0441471 | denotes | events |
| E4-ab-5 | 701-705 | cui:C1332709 | denotes | CD28 |
| E5-ab-5 | 723-727 | cui:C0879590 | denotes | IL-2 |
| E6-ab-5 | 728-738 | cui:C0033268 | denotes | production |
| E7-ab-5 | 742-744 | cui:C1179187 | denotes | LP |
| E8-ab-5 | 745-762 | cui:C0806987 | denotes | mononuclear cells |
| T8 | 742-762 | PART_OF | denotes | LP mononuclear cells |
| T9 | 739-741 | LOCATION_OF | denotes | in |
| E1-ab-6 | 786-795 | cui:C0205217 | denotes | increased |
| E2-ab-6 | 796-800 | cui:C0879590 | denotes | IL-2 |
| E3-ab-6 | 801-811 | cui:C0033268 | denotes | production |
| E4-ab-6 | 815-823 | cui:C0871261 | denotes | response |
| E5-ab-6 | 827-831 | cui:C1332709 | denotes | CD28 |
| E6-ab-6 | 861-866 | cui:C0007634 | denotes | cells |
| E7-ab-6 | 885-888 | cui:C1367475 | denotes | CD2 |
| T10 | 867-876 | STIMULATES | denotes | activated |
| E1-ab-7 | 896-900 | cui:C0879590 | denotes | IL-2 |
| E2-ab-7 | 901-910 | cui:C0015283 | denotes | secretion |
| E3-ab-7 | 929-938 | cui:C0205217 | denotes | increased |
| E4-ab-7 | 939-949 | cui:C0185117 | denotes | expression |
| E5-ab-7 | 953-957 | cui:C0879590 | denotes | IL-2 |
| E6-ab-7 | 958-962 | cui:C0035696 | denotes | mRNA |
| E7-ab-7 | 988-992 | cui:C0879590 | denotes | IL-2 |
| E8-ab-7 | 993-1007 | cui:C1257757 | denotes | mRNA stability |
| E1-ab-8 | 1024-1050 | cui:C0162493 | denotes | transcriptional activation |
| E2-ab-8 | 1060-1064 | cui:C0872343 | denotes | EMSA |
| E3-ab-8 | 1079-1083 | cui:C1332709 | denotes | CD28 |
| E4-ab-8 | 1098-1101 | cui:C1367475 | denotes | CD2 |
| E5-ab-8 | 1102-1111 | cui:C1515877 | denotes | activated |
| E6-ab-8 | 1122-1125 | cui:C1518422 | denotes | not |
| E7-ab-8 | 1136-1145 | cui:C0205217 | denotes | increased |
| E8-ab-8 | 1163-1170 | cui:C1521761 | denotes | factors |
| E9-ab-8 | 1178-1184 | cui:C1332709 | denotes | CD28RE |
| E10-ab-8 | 1178-1184 | cui:C0600508 | denotes | CD28RE |
| E11-ab-8 | 1194-1207 | cui:C0949466 | denotes | Western blots |
| E12-ab-8 | 1215-1222 | cui:C0392747 | denotes | changes |
| E13-ab-8 | 1256-1262 | cui:C0441889 | denotes | levels |
| E14-ab-8 | 1273-1277 | cui:C1332709 | denotes | CD28 |
| E1-ab-9 | 1303-1307 | cui:C1332709 | denotes | CD28 |
| E2-ab-9 | 1336-1340 | cui:C0879590 | denotes | IL-2 |
| E3-ab-9 | 1350-1358 | cui:C0335038 | denotes | reporter |
| E4-ab-9 | 1378-1388 | cui:C0185117 | denotes | expression |
| E5-ab-9 | 1392-1395 | cui:C1367475 | denotes | CD2 |
| E6-ab-9 | 1396-1405 | cui:C1515877 | denotes | activated |
| E1-ab-10 | 1416-1423 | cui:C1274040 | denotes | results |
| E2-ab-10 | 1458-1467 | cui:C1521991 | denotes | molecular |
| E3-ab-10 | 1468-1478 | cui:C0441712 | denotes | mechanisms |
| E4-ab-10 | 1491-1495 | cui:C1332709 | denotes | CD28 |
| E5-ab-10 | 1512-1522 | cui:C0851285 | denotes | regulation |
| E6-ab-10 | 1526-1530 | cui:C0879590 | denotes | IL-2 |
| E7-ab-10 | 1531-1540 | cui:C0015283 | denotes | secretion |
| E8-ab-10 | 1544-1546 | cui:C1179187 | denotes | LP |
| E9-ab-10 | 1547-1554 | cui:C0039194 | denotes | T cells |
| E10-ab-10 | 1574-1585 | cui:C1185625 | denotes | compartment |
| E11-ab-10 | 1616-1640 | cui:C0005773 | denotes | peripheral blood T cells |
| T11 | 1544-1554 | PART_OF | denotes | LP T cells |
| T12 | 1541-1543 | LOCATION_OF | denotes | in |
| T13 | 1613-1615 | LOCATION_OF | denotes | in |
| E1-ab-11 | 1671-1681 | cui:C0205460 | denotes | biological |
| E2-ab-11 | 1682-1694 | cui:C0750502 | denotes | significance |
| E3-ab-11 | 1699-1708 | cui:C1547020 | denotes | different |
| E4-ab-11 | 1709-1719 | cui:C0441712 | denotes | mechanisms |
| E5-ab-11 | 1723-1727 | cui:C0879590 | denotes | IL-2 |
| E6-ab-11 | 1757-1768 | cui:C0024501 | denotes | maintenance |
| E7-ab-11 | 1776-1784 | cui:C0079189 | denotes | cytokine |
| E8-ab-11 | 1809-1815 | cui:C0026724 | denotes | mucosa |
| R1 | E6-ti-1 | T1 | subjectOf | T cells,lamina propria T cells |
| R2 | E5-ti-1 | T1 | objectOf | lamina propria,lamina propria T cells |
| R3 | E2-ti-1 | T2 | subjectOf | IL-2,of |
| R4 | E6-ti-1 | T2 | objectOf | T cells,of |
| R5 | E2-ab-1 | T3 | subjectOf | T cells,lamina propria (LP) T cells |
| R6 | E1-ab-1 | T3 | objectOf | lamina propria,lamina propria (LP) T cells |
| R7 | E2-ab-2 | T4 | subjectOf | T cells,LP T cells |
| R8 | E1-ab-2 | T4 | objectOf | LP,LP T cells |
| R9 | E3-ab-2 | T5 | subjectOf | IL-2,activated |
| R10 | E5-ab-2 | T5 | objectOf | CD2,activated |
| R11 | E1-ab-3 | T6 | subjectOf | CD28,enhancement |
| R12 | E2-ab-3 | T6 | objectOf | IL-2,enhancement |
| R13 | E4-ab-4 | T7 | subjectOf | augmentation,mediated |
| R14 | E9-ab-4 | T7 | objectOf | transcriptional activation,mediated |
| R15 | E8-ab-5 | T8 | subjectOf | mononuclear cells,LP mononuclear cells |
| R16 | E7-ab-5 | T8 | objectOf | LP,LP mononuclear cells |
| R17 | E8-ab-5 | T9 | subjectOf | mononuclear cells,in |
| R18 | E5-ab-5 | T9 | objectOf | IL-2,in |
| R19 | E2-ab-6 | T10 | subjectOf | IL-2,activated |
| R20 | E7-ab-6 | T10 | objectOf | CD2,activated |
| R21 | E9-ab-10 | T11 | subjectOf | T cells,LP T cells |
| R22 | E8-ab-10 | T11 | objectOf | LP,LP T cells |
| R23 | E9-ab-10 | T12 | subjectOf | T cells,in |
| R24 | E6-ab-10 | T12 | objectOf | IL-2,in |
| R25 | E11-ab-10 | T13 | subjectOf | peripheral blood T cells,in |
| R26 | E10-ab-10 | T13 | objectOf | compartment,in |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-152 | Sentence | denotes | CD28 costimulation augments IL-2 secretion of activated lamina propria T cells by increasing mRNA stability without enhancing IL-2 gene transactivation. |
| S2 | 153-257 | Sentence | denotes | The pathways leading to activation in lamina propria (LP) T cells are different from peripheral T cells. |
| S3 | 258-340 | Sentence | denotes | LP T cells exhibit enhanced IL-2 secretion when activated through the CD2 pathway. |
| S4 | 341-411 | Sentence | denotes | Coligation of CD28 leads to synergistic enhancement of IL-2 secretion. |
| S5 | 412-646 | Sentence | denotes | Previous studies have characterized the CD28 augmentation of TCR-mediated signaling in peripheral blood T cells through transcriptional activation of an IL-2 promoter CD28 response element (CD28RE), along with enhanced mRNA stability. |
| S6 | 647-770 | Sentence | denotes | This study characterized molecular events involved in CD28 costimulation of IL-2 production in LP mononuclear cells (LPMC). |
| S7 | 771-895 | Sentence | denotes | LPMC exhibited increased IL-2 production in response to CD28 costimulation, compared with cells activated through CD2 alone. |
| S8 | 896-1008 | Sentence | denotes | IL-2 secretion was paralleled by increased expression of IL-2 mRNA, resulting from enhanced IL-2 mRNA stability. |
| S9 | 1009-1289 | Sentence | denotes | In contrast to transcriptional activation in PBMC, EMSA revealed that CD28 coligation of CD2-activated LPMC does not result in increased binding of trans-factors to the CD28RE, nor did Western blots detect changes in I-kappaBalpha or I-kappaBbeta levels following CD28 coligation. |
| S10 | 1290-1411 | Sentence | denotes | Furthermore, CD28 coligation fails to enhance IL-2 promoter-reporter or RE/AP construct expression in CD2-activated LPMC. |
| S11 | 1412-1641 | Sentence | denotes | The results reported herein indicate that the molecular mechanisms involved in CD28 cosignaling and regulation of IL-2 secretion in LP T cells are unique to that compartment and differ from those seen in peripheral blood T cells. |
| S12 | 1642-1816 | Sentence | denotes | These observations suggest a biological significance for different mechanisms of IL-2 activation in initiation and maintenance of the cytokine repertoire found in the mucosa. |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 0-18 | NP | denotes | CD28 costimulation |
| C2 | 191-218 | NP | denotes | lamina propria (LP) T cells |
| C3 | 238-256 | NP | denotes | peripheral T cells |
| C4 | 258-268 | NP | denotes | LP T cells |
| C5 | 341-359 | NP | denotes | Coligation of CD28 |
| C6 | 396-410 | NP | denotes | IL-2 secretion |
| C7 | 499-523 | NP | denotes | peripheral blood T cells |
| C8 | 562-609 | NP | denotes | an IL-2 promoter CD28 response element (CD28RE) |
| C9 | 742-769 | NP | denotes | LP mononuclear cells (LPMC) |
| C10 | 771-775 | NP | denotes | LPMC |
| C11 | 827-845 | NP | denotes | CD28 costimulation |
| C12 | 896-910 | NP | denotes | IL-2 secretion |
| C13 | 1098-1116 | NP | denotes | CD2-activated LPMC |
| C14 | 1174-1184 | NP | denotes | the CD28RE |
| C15 | 1273-1288 | NP | denotes | CD28 coligation |
| C16 | 1303-1318 | NP | denotes | CD28 coligation |
| C17 | 1392-1410 | NP | denotes | CD2-activated LPMC |
| C18 | 1454-1478 | NP | denotes | the molecular mechanisms |
| C19 | 1526-1540 | NP | denotes | IL-2 secretion |
| C20 | 1544-1554 | NP | denotes | LP T cells |
| C21 | 1602-1607 | NP | denotes | those |
| C22 | 1616-1640 | NP | denotes | peripheral blood T cells |
| R1 | C4 | C2 | coref-ident | LP T cells,lamina propria (LP) T cells |
| R2 | C7 | C3 | coref-ident | peripheral blood T cells,peripheral T cells |
| R3 | C10 | C9 | coref-ident | LPMC,LP mononuclear cells (LPMC) |
| R4 | C11 | C1 | coref-ident | CD28 costimulation,CD28 costimulation |
| R5 | C12 | C6 | coref-ident | IL-2 secretion,IL-2 secretion |
| R6 | C14 | C8 | coref-ident | the CD28RE,an IL-2 promoter CD28 response element (CD28RE) |
| R7 | C15 | C5 | coref-ident | CD28 coligation,Coligation of CD28 |
| R8 | C16 | C15 | coref-ident | CD28 coligation,CD28 coligation |
| R9 | C17 | C13 | coref-ident | CD2-activated LPMC,CD2-activated LPMC |
| R10 | C19 | C12 | coref-ident | IL-2 secretion,IL-2 secretion |
| R11 | C20 | C4 | coref-ident | LP T cells,LP T cells |
| R12 | C21 | C18 | coref-pron | those,the molecular mechanisms |
| R13 | C22 | C7 | coref-ident | peripheral blood T cells,peripheral blood T cells |
metamap-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 262-269 | C0039194 | denotes | cells |
| T2 | 72-79 | C0039194 | denotes | cells |
| T3 | 137-152 | C0040624 | denotes | ransactivation. |
| T4 | 994-1008 | C1257757 | denotes | RNA stability. |
| T5 | 632-646 | C1257757 | denotes | RNA stability. |
| T6 | 94-108 | C1257757 | denotes | RNA stability |
| T7 | 1545-1547 | C1179187 | denotes | P |
| T8 | 743-745 | C1179187 | denotes | P |
| T9 | 259-261 | C1179187 | denotes | P |
| T10 | 192-206 | C1179187 | denotes | amina propria |
| T11 | 57-71 | C1179187 | denotes | amina propria |
| T12 | 897-911 | C2754073 | denotes | L-2 secretion |
| T13 | 397-411 | C2754073 | denotes | L-2 secretion. |
| T14 | 287-301 | C2754073 | denotes | L-2 secretion |
| T15 | 29-43 | C2754073 | denotes | L-2 secretion |
| T16 | 1137-1146 | C0205217 | denotes | ncreased |
| T17 | 930-939 | C0205217 | denotes | ncreased |
| T18 | 787-796 | C0205217 | denotes | ncreased |
| T19 | 20-28 | C0205217 | denotes | ugments |
| T20 | 1329-1336 | C2349975 | denotes | nhance |
| T21 | 980-988 | C2349975 | denotes | nhanced |
| T22 | 623-631 | C2349975 | denotes | nhanced |
| T23 | 382-393 | C2349975 | denotes | nhancement |
| T24 | 278-286 | C2349975 | denotes | nhanced |
| T25 | 117-126 | C2349975 | denotes | nhancing |
| T26 | 127-136 | C1705753 | denotes | L-2 gene |
| T27 | 1729-1739 | C1879547 | denotes | ctivation |
| T28 | 1397-1406 | C1879547 | denotes | ctivated |
| T29 | 1103-1112 | C1879547 | denotes | ctivated |
| T30 | 868-877 | C1879547 | denotes | ctivated |
| T31 | 307-316 | C1879547 | denotes | ctivated |
| T32 | 178-188 | C1879547 | denotes | ctivation |
| T33 | 47-56 | C1879547 | denotes | ctivated |
| T34 | 83-93 | C0442808 | denotes | ncreasing |
| T35 | 1179-1185 | C0600508 | denotes | D28RE, |
| T36 | 585-601 | C0600508 | denotes | esponse element |
| T37 | 777-786 | C0015272 | denotes | xhibited |
| T38 | 270-277 | C0015272 | denotes | xhibit |
| T39 | 1025-1051 | C0162493 | denotes | ranscriptional activation |
| T40 | 533-559 | C0162493 | denotes | ranscriptional activation |
| T41 | 474-477 | C0034790 | denotes | CR- |
| T42 | 1649-1661 | C0700325 | denotes | bservations |
| T43 | 1195-1208 | C0949466 | denotes | estern blots |
| T44 | 1724-1726 | C0021764 | denotes | L- |
| T45 | 1061-1065 | C0949632 | denotes | MSA |
| T46 | 1337-1341 | C0879590 | denotes | L-2 |
| T47 | 566-570 | C0879590 | denotes | L-2 |
| T48 | 1393-1396 | C1367475 | denotes | D2- |
| T49 | 1099-1102 | C1367475 | denotes | D2- |
| T50 | 886-889 | C1367475 | denotes | D2 |
| T51 | 329-332 | C1367475 | denotes | D2 |
| T52 | 1777-1784 | C0079189 | denotes | ytokine |
| T53 | 487-496 | C0037083 | denotes | ignaling |
| T54 | 659-672 | C1880022 | denotes | haracterized |
| T55 | 435-448 | C1880022 | denotes | haracterized |
| T56 | 1810-1816 | C0026724 | denotes | ucosa. |
| T57 | 333-340 | C1704259 | denotes | athway. |
| T58 | 158-166 | C1704259 | denotes | athways |
| T59 | 1417-1424 | C2825142 | denotes | esults |
| T60 | 1127-1133 | C2825142 | denotes | esult |
| T61 | 797-812 | C1819447 | denotes | L-2 production |
| T62 | 724-739 | C1819447 | denotes | L-2 production |
| T63 | 1480-1488 | C1314939 | denotes | nvolved |
| T64 | 690-698 | C1314939 | denotes | nvolved |
| T65 | 1710-1720 | C0441712 | denotes | echanisms |
| T66 | 1469-1479 | C0441712 | denotes | echanisms |
| T67 | 1459-1467 | C1521991 | denotes | olecular |
| T68 | 673-682 | C1521991 | denotes | olecular |
| T69 | 1700-1708 | C1705242 | denotes | ifferent |
| T70 | 224-232 | C1705242 | denotes | ifferent |
| T71 | 1342-1350 | C0086860 | denotes | romoter- |
| T72 | 571-579 | C0086860 | denotes | romoter |
| T73 | 1758-1769 | C0024501 | denotes | aintenance |
| T74 | 1575-1586 | C1185625 | denotes | ompartment |
| T75 | 1209-1215 | C0442726 | denotes | etect |
| T76 | 1320-1325 | C0231175 | denotes | ails |
| T77 | 1264-1273 | C0332282 | denotes | ollowing |
| T78 | 1123-1126 | C1518422 | denotes | ot |
| T79 | 1055-1059 | C1321301 | denotes | BMC, |
| T80 | 1425-1433 | C0684224 | denotes | eported |
| T81 | 1066-1074 | C0443289 | denotes | evealed |
| T82 | 653-658 | C2603343 | denotes | tudy |
| T83 | 1326-1328 | C1883351 | denotes | o |
| T84 | 1743-1753 | C1158830 | denotes | nitiation |
| T85 | 890-895 | C0679994 | denotes | lone. |
| T86 | 1513-1541 | C3269319 | denotes | egulation of IL-2 secretion |
| T87 | 1662-1669 | C1705535 | denotes | uggest |
| T88 | 683-688 | C0441471 | denotes | vents |
| T89 | 746-763 | C0806987 | denotes | ononuclear cells |
| T90 | 422-429 | C0947630 | denotes | tudies |
| T91 | 1560-1566 | C1710548 | denotes | nique |
| T92 | 1351-1359 | C1709908 | denotes | eporter |
| T93 | 862-867 | C0007634 | denotes | ells |
| T94 | 848-856 | C1707455 | denotes | ompared |
| T95 | 167-174 | C1522538 | denotes | eading |
| T96 | 1216-1223 | C0443172 | denotes | hanges |
| T97 | 1797-1802 | C0150312 | denotes | ound |
| T98 | 1609-1613 | C0205397 | denotes | een |
| T99 | 458-470 | C1293122 | denotes | ugmentation |
| T100 | 1147-1154 | C1167622 | denotes | inding |
| T101 | 965-974 | C0678226 | denotes | esulting |
| T102 | 1379-1389 | C0185117 | denotes | xpression |
| T103 | 1158-1163 | C2826298 | denotes | rans- |
| T104 | 361-366 | C2348269 | denotes | eads |
| T105 | 370-380 | C2986495 | denotes | ynergistic |
| T106 | 1683-1695 | C0750502 | denotes | ignificance |
| T107 | 1164-1171 | C1521761 | denotes | actors |
| T108 | 916-926 | C2826345 | denotes | aralleled |
| T109 | 413-421 | C0205156 | denotes | revious |
| T110 | 1227-1228 | C0221138 | denotes | - |
| T111 | 239-249 | C0205100 | denotes | eripheral |
| T112 | 816-824 | C0871261 | denotes | esponse |
| T113 | 1369-1378 | C2827421 | denotes | onstruct |
| T114 | 478-486 | C0127400 | denotes | ediated |
| T115 | 1672-1682 | C0205460 | denotes | iological |